
    
      It will compare the efficacy, safety and tolerability of twice daily ChronocortÂ® with
      standard care (using the participant's usual individualized standard glucocorticoid regimen)
      over a treatment period of 52 weeks in participants aged 16 years and over with known CAH due
      to 21-hydroxylase deficiency (classic CAH) diagnosed in childhood with documented (at any
      time) elevated 17-OHP or A4 and currently treated with hydrocortisone, prednisone,
      prednisolone or dexamethasone (or a combination of the aforementioned glucocorticoids).
    
  